首页> Clinical cancer research : an official journal of the American Association for Cancer Research> Inhibition of ID1-BMPR2 Intrinsic Signaling Sensitizes Glioma Stem Cells to Differentiation Therapy.

Inhibition of ID1-BMPR2 Intrinsic Signaling Sensitizes Glioma Stem Cells to Differentiation Therapy.

导出原文传递

翻译打印收藏纠错

第一作者： Xiong,Jin

第一单位： Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea.;Institute of Animal Molecular Biotechnology, Korea University, Seoul, Republic of Korea.

作者： Xiong,Jin ^[1] ; Xun,Jin ^[2] ; Leo J Y,Kim ^[3] ; Deobrat,Dixit ^[3] ; Hee-Young,Jeon ^[1] ; Eun-Jung,Kim ^[1] ; Jun-Kyum,Kim ^[1] ; Seon Yong,Lee ^[4] ; Jinlong,Yin ^[5] ; Jeremy N,Rich ^[3] ; Hyunggee,Kim ^[6]

作者单位： Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea.;Institute of Animal Molecular Biotechnology, Korea University, Seoul, Republic of Korea. ^[1] Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio. hg-kim@korea.ac.kr jinx2354@163.com.;Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.;Institute of Translational Medicine, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. ^[2] Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio. ^[3] Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea. ^[4] Specific Organ Cancer Division, Research Institute and hospital, National Cancer Center, Goyang, Republic of Korea. ^[5] Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea. hg-kim@korea.ac.kr jinx2354@163.com.;Institute of Animal Molecular Biotechnology, Korea University, Seoul, Republic of Korea. ^[6]